Cargando…
The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series)
Increased synthesis of serotonin and/or activity of serotonin in pulmonary arteries has been implicated in the pathobiology of pulmonary arterial hypertension (PAH). The incidence of PAH associated with diet pills such as aminorex, fenfluramine, and chlorphentermine initially led to the “serotonin h...
Autor principal: | MacLean, Margaret (Mandy) R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826007/ https://www.ncbi.nlm.nih.gov/pubmed/29468941 http://dx.doi.org/10.1177/2045894018759125 |
Ejemplares similares
-
The role of endothelial leak in pulmonary hypertension (2017 Grover Conference Series)
por: Zhou, Chun, et al.
Publicado: (2018) -
Mechanisms of right heart disease in pulmonary hypertension (2017 Grover Conference Series)
por: Asosingh, Kewal, et al.
Publicado: (2017) -
Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)
por: Ranchoux, Benoît, et al.
Publicado: (2017) -
BMPR2 mutations and endothelial dysfunction in
pulmonary arterial hypertension (2017 Grover Conference Series)
por: Frump, Andrea, et al.
Publicado: (2018) -
Difficulties in modelling ARDS (2017 Grover Conference Series)
por: Uhlig, Stefan, et al.
Publicado: (2018)